$45.20
00.00%
Last update: Jul 19, 4:01 PM
15 minutes delayed
Comments
Loading...
iRadimed
IRMDNASDAQ
iRadimed (NASDAQ:IRMD) Stock, Analyst Ratings, Price Targets, Forecasts
iRadimed Corp has a consensus price target of $50.5 based on the ratings of 2 analysts. The high is $65 issued by Roth MKM on April 22, 2024. The low is $36 issued by Roth Capital on August 2, 2021. The 2 most-recent analyst ratings were released by Roth MKM and Roth Capital on April 22, 2024 and August 2, 2021, respectively. With an average price target of $50.5 between Roth MKM and Roth Capital, there's an implied 11.73% upside for iRadimed Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Roth MKM
Roth Capital
1calculated from analyst ratings
Analyst Ratings for iRadimed
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/22/2024 | Buy Now | 43.81% | Roth MKM | Jason Wittes | → $65 | Reinstates | → Buy | Get Alert |
| 08/02/2021 | Buy Now | -20.35% | Roth Capital | Scott Henry | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for iRadimed (IRMD) stock?
The latest price target for iRadimed (NASDAQ:IRMD) was reported by Roth MKM on April 22, 2024. The analyst firm set a price target for $65.00 expecting IRMD to rise to within 12 months (a possible 43.81% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for iRadimed (IRMD)?
The latest analyst rating for iRadimed (NASDAQ:IRMD) was provided by Roth MKM, and iRadimed their buy rating.
When was the last upgrade for iRadimed (IRMD)?
There is no last upgrade for iRadimed
When was the last downgrade for iRadimed (IRMD)?
There is no last downgrade for iRadimed.
When is the next analyst rating going to be posted or updated for iRadimed (IRMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iRadimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iRadimed was filed on April 22, 2024 so you should expect the next rating to be made available sometime around April 22, 2025.
Is the Analyst Rating iRadimed (IRMD) correct?
While ratings are subjective and will change, the latest iRadimed (IRMD) rating was a with a price target of $0.00 to $65.00. The current price iRadimed (IRMD) is trading at is $45.20, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.